Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 18 and up

Non-invasive detection of coronary stent complications using a new device

Official title: First-in-human Study to Assess the Clinical Feasibility, Safety, and Performance of the α Prototype of the NIMBLE System for Diagnosing Complications in Intracoronary Stents. NIMBLE-I Study.

Run by Nimble Diagnostics S.L. · NCT06968858 · Data updated 2026-11-12

This study is testing a new non-invasive device to see if it can safely detect problems with coronary stents in patients who need heart tests.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorNimble Diagnostics S.L.
Industry-sponsored
Locations1 site (Badalona, Catalonia)
StatusRecruiting
StartedSeptember 12, 2024
Main results expectedSeptember 2025
Study endsOctober 2025
Registry record updatedMay 13, 2025
Trial IDNCT06968858 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients who have had one or more coronary stents implanted and are experiencing symptoms suggestive of stent failure.

Probably not a fit

Patients with implanted electronic devices like pacemakers or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The NIMBLE-I study is a pilot clinical trial evaluating the feasibility and safety of a novel non-invasive device called the NIMBLE system for detecting complications related to coronary stents, particularly in-stent restenosis. Conducted at the Hospital Germans Trias i Pujol in Spain, this single-center trial aims to provide a safer alternative to traditional invasive diagnostic methods. The NIMBLE system utilizes microwave interferometry to monitor changes in the stent environment without the need for ionizing radiation or invasive procedures. The study will assess the usability and preliminary performance of this innovative approach in patients scheduled for coronary angiography.

Why it matters

Potential benefit: If successful, this device could significantly reduce the need for invasive procedures in monitoring coronary stent complications, improving patient safety and comfort.

How similar studies have gone: While the approach of using non-invasive monitoring for stent complications is innovative, similar studies have shown promise in other non-invasive diagnostic technologies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Prior implantation of one or more coronary stents
* Clinical symptoms suggestive of stent failure (e.g., chest pain, ischemic ECG changes)
* Undergoing scheduled coronary angiography
* Informed consent provided

Exclusion Criteria:

* Pregnancy
* Implanted electronic devices (e.g., pacemakers) that may interfere with MWI
* Inability to provide consent
* Chest conditions preventing correct positioning of the device

Where it's running

  • Hospital Universitari Germans Trias i Pujol
    Badalona, Catalonia, Spain
    Recruiting

Study contacts

  • Principal investigator: Oriol Rodriguez-Leor, MD, PhD — Germans Trias i Pujol Hospital

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.